JHC
CRBP icon

Jones Hill Capital’s Corbus Pharmaceuticals CRBP Stock Holding History

Jones Hill Capital’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.13M Buy
+653,572
New +$6.19M 1.3% 23

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $214M AUM 88.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return

Jones Hill Capital's CRBP Position: Q2 2026 in Review

Jones Hill Capital opened a new position in Corbus Pharmaceuticals (CRBP) in Q2 2026: 653,572 shares worth $6.13M. The stake represents 1.3% of the portfolio and ranks #23 among its holdings.

107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Jones Hill Capital held 653,572 shares of Corbus Pharmaceuticals worth $6.13M as of Q2 2026.
  • Corbus Pharmaceuticals was a new Jones Hill Capital position in Q2 2026.
  • Corbus Pharmaceuticals made up 1.3% of Jones Hill Capital's portfolio in Q2 2026, its #23 holding.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Jones Hill Capital's 13F filing for Q2 2026, filed 13 Aug 2026.